| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Revenue | $5.42B | +9.7% |
| Cost of Revenue | $1.97B | +5.2% |
| R&D Expense | $841.0M | +3.7% |
| SG&A Expense | $1.28B | +7.4% |
| Operating Income | $1.33B | +23.5% |
| Interest Expense | $79.0M | +0.0% |
| Pre-tax Income | $1.28B | +27.2% |
| Income Tax | $161.0M | +38.8% |
| Net Income | $1.12B |
| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.04B | -0.5% |
| Accounts Receivable | $905.0M | +23.1% |
| Inventory | $858.0M | +10.4% |
| Current Assets | $4.23B | +10.4% |
| Total Assets | $8.10B | +4.1% |
| Current Liabilities | $1.41B | +7.5% |
| Long-term Debt | $1.79B | +0.1% |
| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.14B | -13.5% |
| Capital Expenditures | $185.0M | +6.3% |
| Investing Cash Flow | -$251.0M | +28.9% |
| Financing Cash Flow | -$861.0M | -28.3% |
| Free Cash Flow | $959.0M | -16.5% |
| +25.7% |
| EPS (Basic) | $6.23 | +28.7% |
| EPS (Diluted) | $6.18 | +29.3% |
| Total Liabilities |
| $3.94B |
| -1.5% |
| Stockholders' Equity | $4.16B | +10.0% |